KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2025)

Vir Biotechnology's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.07 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 41.26% to 0.07 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07, a 41.26% increase, with the full-year FY2025 number at 0.06, up 27.63% from a year prior.
  • Asset Utilization Ratio hit 0.07 in Q4 2025 for Vir Biotechnology, up from 0.02 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for VIR hit a ceiling of 0.96 in Q1 2022 and a floor of 0.02 in Q2 2025.
  • Historically, Asset Utilization Ratio has averaged 0.26 across 5 years, with a median of 0.06 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: surged 1909.12% in 2022 and later plummeted 94.02% in 2023.
  • Tracing VIR's Asset Utilization Ratio over 5 years: stood at 0.69 in 2021, then fell by 10.11% to 0.62 in 2022, then tumbled by 92.96% to 0.04 in 2023, then increased by 10.39% to 0.05 in 2024, then skyrocketed by 41.26% to 0.07 in 2025.
  • Business Quant data shows Asset Utilization Ratio for VIR at 0.07 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.